Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD)

PHASE3CompletedINTERVENTIONAL
Enrollment

990

Participants

Timeline

Start Date

December 14, 2016

Primary Completion Date

May 26, 2020

Study Completion Date

May 26, 2020

Conditions
COPD (Chronic Obstructive Pulmonary Disease)
Interventions
DRUG

CHF 5993 100/6/12.5 µg

Fixed combination of extrafine beclometasone dipropionate 100 µg plus formoterol fumarate 6 µg plus glycopyrronium bromide 12.5 µg / metered dose

DRUG

160 µg budesonide + 4.5 µg formoterol fumarate

Fixed combination of budesonide 160 µg plus formoterol fumarate 4.5 µg

Trial Locations (67)

204

Chiesi Clinical Trial Site 158001, Keelung

220

Chiesi Clinical Trial Site 158011, Taipei

500

Chiesi Clinical Trial Site 158010, Changhua

Chiesi Clinical Trial Site 158010, Changhua

824

Chiesi Clinical Trial Site 158006, Kaohsiung City

2559

Chiesi Clinical Trial Site 410013, Seoul

5030

Chiesi Clinical Trial Site 410014, Seoul

10380

Chiesi Clinical Trial Site 410002, Goyang-si

11217

Chiesi Clinical Trial Site 158005, Taipei

14584

Chiesi Clinical Trial Site 410012, Bucheon-si

24289

Chiesi Clinical Trial Site 410003, Chuncheon

54907

Chiesi Clinical Trial Site 410005, Jeonju

64041

Chiesi Clinical Trial Site 158003, Douliu

83301

Chiesi Clinical Trial Site 158004, Kaohsiung City

100000

Chiesi clinical Trial Site 156031, Beijing

100020

Chiesi Clinical Trial Site 156026, Beijing

100029

Chiesi clinical Trial Site 156017, Beijing

100144

Chiesi Clinical Trial Site 156012, Beijing

110004

Chiesi Clinical Trial Site 156007, Shenyang

130000

Chiesi clinical Trial Site 156023, Changchun

Chiesi Clinical Trial Site 156036, Changchun

130021

Chiesi clinical Trial Site 156019, Changchun

200025

Chiesi Clinical Trial Site 156014, Shanghai

200031

Chiesi clinical Trial Site 156037, Shanghai

200072

Chiesi Clinical Trial Site 156005, Shanghai

200433

Chiesi Clinical Trial Site 156006, Shanghai

Chiesi Clinical Trial Site 156011, Shanghai

210006

Chiesi clinical Trial Site 156022, Nanjing

210009

Chiesi Clinical Trial Site 156038, Shanghai

215000

Chiesi Clinical Trial Site 156049, Suzhou

223300

Chiesi Clinical Trial Site 156004, Huai'an

300052

Chiesi clinical Trial Site 156034, Tianjin

310014

Chiesi clinical Trial Site 156018, Hangzhou

317000

Chiesi Clinical Trial Site 156046, Linhai

320281

Chiesi clinical Trial Site 156033, Jiangyin

330000

Chiesi Clinical Trial Site 156041, Nanchang

330006

Chiesi clinical Trial Site 156028, Nanchang

332000

Chiesi Clinical Trial Site 156047, Jiujiang

337000

Chiesi Clinical Trial Site 156042, Pingxiang

350005

Chiesi Clinical Trial Site 156002, Fuzhou

400000

Chiesi Clinical Trial Site 156045, Chongqing

Chiesi clinical Trial Site 156032, Chongqing

410000

Chiesi Clinical Trial Site 156040, Changsha

410011

Chiesi Clinical Trial Site 156040, Changsha

510000

Chiesi Clinical Trial Site 156048, Guangzhou

510080

Chiesi Clinical Trial Site 156013, Guangzhou

510120

The First Affiliated Hospital of Guangzhou Medical University site 156001, Guanzhou

524000

Chiesi Clinical Trial Site 156008, Zhanjiang

528000

Chiesi clinical Trial Site 156024, Foshan

530021

Chiesi Clinical Trial site 156003, Nanning

570100

Chiesi clinical Trial Site 156020, Haikou

610000

Chiesi clinical Trial Site 156035, Chengdu

610041

Chiesi Clinical Trial Site 156010, Chengdu

750000

Chiesi clinical Trial Site 156025, Yinchuan

050000

Chiesi Clinical Trial Site 156044, Shijiangzhuang

014000

Chiesi Clinical Trial Site 156043, Baotou

014010

Chiesi Clinical Trial Site 156015, Baotou

030001

Chiesi Clinical Trial Site 156039, Taiyuan

420-717

Chiesi Clinical Trial Site 410001, Bucheon-si

07345

Chiesi Clinical Trial Site 410008, Seoul

07985

Chiesi Clinical Trial Site 410007, Seoul

100-032

Chiesi Clinical Trial Site 410004, Seoul

136-705

Chiesi Clinical Trial Site 410006, Seoul

135-720

Chiesi Clinical Trial Site 410009, Gyeonggi-do

705-703

Chiesi Clinical Trial Site 410010, Daegu

04401

Chiesi Clinical Trial Site 410011, Seoul

Unknown

Chiesi Clinical Trial Site 158008, Taichung

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT03197818 - Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) | Biotech Hunter | Biotech Hunter